アキュルナ株式会社 (Accurna)
acquired by NanoCarrier2 known investors
AccuRna develops drug delivery systems (DDS) for nucleic acid therapeutics. The company is engaged in partnering and collaboration discussions.
Investors · 2
Frequently asked questions
- What does アキュルナ株式会社 (Accurna) do?
- AccuRna develops drug delivery systems (DDS) for nucleic acid therapeutics. The company is engaged in partnering and collaboration discussions.
- Who are アキュルナ株式会社 (Accurna)'s investors?
- アキュルナ株式会社 (Accurna)'s investors include Fast Track Initiative, UTokyo Innovation Platform Co. Ltd..
- Who acquired アキュルナ株式会社 (Accurna)?
- アキュルナ株式会社 (Accurna) was acquired by NanoCarrier.